Nimotuzumab Clinical Trials
17 recruitingDrug
Phase 212Phase 34Not Applicable1Phase 11
Showing 1–17 of 17 trials
Recruiting
Phase 2
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
Resectable Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital46 enrolled1 locationNCT07457528
Recruiting
Phase 3
Neoadjuvant Treatment Modalities in Esophageal Cancer
Esophageal CancerSurgeryChemotherapy Effect+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2,000 enrolled1 locationNCT04821843
Recruiting
Phase 3
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Esophagus CancerChemotherapy EffectTargeted Therapy+3 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2,000 enrolled5 locationsNCT04821778
Recruiting
Phase 2
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Head & Neck Cancer
Tang-Du Hospital10 enrolled1 locationNCT07353723
Recruiting
Phase 3
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Head & Neck CancerHead & Neck Squamous Cell Carcinoma
Shandong Cancer Hospital and Institute335 enrolled1 locationNCT07333274
Recruiting
Phase 1Phase 2
HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma (PDAC)
West China Hospital20 enrolled1 locationNCT06773130
Recruiting
Phase 2
HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
Metastatic Pancreatic Carcinoma
Zhejiang University32 enrolled2 locationsNCT06770452
Recruiting
Phase 2
Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma by AJCC V8 Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06509009
Recruiting
Phase 2
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen208 enrolled6 locationsNCT07070479
Recruiting
Phase 2
Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University95 enrolled1 locationNCT06988956
Recruiting
Phase 2
TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University70 enrolled1 locationNCT06912711
Recruiting
Phase 2
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital57 enrolled1 locationNCT06722911
Recruiting
Phase 2
Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University112 enrolled1 locationNCT06718205
Recruiting
Phase 2
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School57 enrolled1 locationNCT06389760
Recruiting
Phase 2
Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure
HCC
Tianjin Medical University Cancer Institute and Hospital30 enrolled1 locationNCT06413017
Recruiting
Phase 3
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
Nasopharyngeal Carcinoma
Fudan University459 enrolled1 locationNCT05772208
Recruiting
Not Applicable
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma by AJCC V8 Stage
Fourth Affiliated Hospital of Guangxi Medical University288 enrolled9 locationsNCT05717790